tiprankstipranks
MEDIQON Group AG (DE:CHG)
XETRA:CHG
Germany Market
Holding DE:CHG?
Track your performance easily

MEDIQON Group AG (CHG) Income Statement

0 Followers

MEDIQON Group AG Income Statement

Last quarter (Q2 2022), MEDIQON Group AG's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, MEDIQON Group AG's net income was €―. See MEDIQON Group AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-€ 28.66M€ 1.08M€ 97.00K€ 2.64M€ 3.21M
Cost of Revenue
-€ 705.65K€ 675.05K€ 522.88K€ 1.53M€ 2.02M
Gross Profit
-€ 27.95M€ 402.76K€ -425.88K€ 1.11M€ 1.19M
Operating Expense
-€ 28.93M€ 296.81K€ 407.18K€ 1.48M€ 666.25K
Operating Income
-€ -981.20K€ 105.95K€ -833.06K€ -375.32K€ 525.15K
Net Non Operating Interest Income Expense
-€ -1.54M€ 293.19K€ 506.42K€ 36.00K€ 30.17K
Other Income Expense
------
Pretax Income
-€ -1.53M€ -2.27M€ -5.01M€ 8.69M€ 541.53K
Tax Provision
-€ 635.38K€ 2.38K€ 0.00€ 1.18M€ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ -1.17M€ -2.27M€ -5.01M€ 7.51M€ 541.53K
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---€ 19.27K€ 81.79K€ 101.33K
Total Expenses
-€ 29.64M€ 971.86K€ 930.06K€ 3.01M€ 2.69M
Net Income From Continuing And Discontinued Operation
-€ -2.27M€ -2.27M€ -5.01M€ 7.51M€ 541.53K
Normalized Income
-€ -3.56M€ -403.62K€ -326.64K€ -293.35K€ 555.32K
Interest Expense
-€ 2.24M€ 937.36K€ 10.57K€ 0.00€ 0.00
EBIT
-€ 700.18K€ -1.33M€ -5.00M€ 8.69M€ 525.15K
EBITDA
-€ 5.87M€ -1.33M€ -4.99M€ 9.02M€ 732.38K
Currency in EUR

MEDIQON Group AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis